Literature DB >> 19902966

Mechanism of fibril formation by a 39-residue peptide (PAPf39) from human prostatic acidic phosphatase.

Zhuqiu Ye1, Kinsley C French, Ludmila A Popova, Igor K Lednev, Maria M Lopez, George I Makhatadze.   

Abstract

PAPf39 is a 39-residue peptide fragment from the sequence of human prostatic acidic phosphatase. This peptide was shown to form amyloid-like fibrils, which have been implicated in facilitating semen-mediated HIV transmission. Thus understanding molecular details of PAPf39 peptide fibril formation may aid in elucidating the mechanism of how PAPf39 fibrils are involved in HIV etiology. To this end, the kinetics of PAPf39 peptide fibrillization was studied using a battery of biophysical methods (atomic force microscopy, ThT fluorescence assays, far-UV circular dichroism spectroscopy, deep-UV resonance Raman spectroscopy, size exclusion chromatography, analytical ultracentrifugation, and small-angle X-ray scattering). It has been shown that fibril formation follows a nucleation-dependent elongation mechanism. Several critical factors for fibrillization have been identified. It was shown that agitation and/or seeding is required for fibril formation at 37 degrees C and neutral pH, with an additional requirement of a salt concentration above approximately 100 mM. Fibril formation by the PAPf39 peptide is inhibited by low pH or by low salt concentration at neutral pH. These observations suggest that the nucleation and fibrillization of the PAPf39 peptide are a tug-of-war between the interactions formed upon agitation and the electrostatic interactions, modulated by pH and salt concentration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902966     DOI: 10.1021/bi901709j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Intramolecular diffusion controls aggregation of the PAPf39 peptide.

Authors:  Kinshuk R Srivastava; Kinsley C French; Franco O Tzul; George I Makhatadze; Lisa J Lapidus
Journal:  Biophys Chem       Date:  2016-06-29       Impact factor: 2.352

2.  The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.

Authors:  Jeffrey R Brender; Ravi Prakash Reddy Nanga; Nataliya Popovych; Ronald Soong; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2011-01-22

3.  Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).

Authors:  Nataliya Popovych; Jeffrey R Brender; Ronald Soong; Subramanian Vivekanandan; Kevin Hartman; Venkatesha Basrur; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  J Phys Chem B       Date:  2012-03-07       Impact factor: 2.991

4.  Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides.

Authors:  David Easterhoff; John T M DiMaio; Todd M Doran; Stephen Dewhurst; Bradley L Nilsson
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

Review 5.  Structure, function and antagonism of semen amyloids.

Authors:  Annika Röcker; Nadia R Roan; Jay Kant Yadav; Marcus Fändrich; Jan Münch
Journal:  Chem Commun (Camb)       Date:  2018-07-05       Impact factor: 6.222

6.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

7.  Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.

Authors:  Kyeong-Ae Kim; Maral Yolamanova; Onofrio Zirafi; Nadia R Roan; Ludger Staendker; Wolf-Georg Forssmann; Adam Burgener; Nathalie Dejucq-Rainsford; Beatrice H Hahn; George M Shaw; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Retrovirology       Date:  2010-06-23       Impact factor: 4.602

8.  Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.

Authors:  Laura M Castellano; Stephen M Bart; Veronica M Holmes; Drew Weissman; James Shorter
Journal:  Chem Biol       Date:  2015-08-06

9.  Bacterial expression and purification of the amyloidogenic peptide PAPf39 for multidimensional NMR spectroscopy.

Authors:  Aranganathan Shanmuganathan; Anthony C Bishop; Kinsley C French; Scott A McCallum; George I Makhatadze
Journal:  Protein Expr Purif       Date:  2013-01-11       Impact factor: 1.650

10.  Core sequence of PAPf39 amyloid fibrils and mechanism of pH-dependent fibril formation: the role of monomer conformation.

Authors:  Kinsley C French; George I Makhatadze
Journal:  Biochemistry       Date:  2012-12-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.